Center Star Asset Management, LLC Astrazeneca PLC Call Options Transaction History

Center Star Asset Management, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Jan 12, 2023	BUY	$54.21 - $70.44 $411,996 - $535,344	7,600 Added 165.22%	12,200 $768,000
Q3 2022 Oct 31, 2022	SELL	$53.02 - $135.75 $2.7 Million - $6.91 Million	-50,900 Reduced 91.71%	4,600 $276,000
Q2 2022 Jul 11, 2022	BUY	$59.26 - $71.14 $296,300 - $355,700	5,000 Added 9.9%	55,500 $3.23 Million
Q1 2022 Apr 25, 2022	BUY	$55.72 - $67.12 $2.81 Million - $3.39 Million	50,500 New	50,500 $2.89 Million
Q3 2021 Nov 02, 2021	SELL	$55.56 - $60.79 $3.52 Million - $3.85 Million	-63,300 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$48.42 - $60.18 $1.81 Million - $2.24 Million	37,300 Added 143.46%	63,300 $3.31 Million
Q1 2021 Apr 23, 2021	BUY	$47.16 - $54.44 $905,471 - $1.05 Million	19,200 Added 282.35%	26,000 $1.37 Million
Q4 2019 Jan 14, 2020	SELL	$42.46 - $50.46 $106,150 - $126,150	-2,500 Reduced 26.88%	6,800 $45,000
Q3 2019 Oct 24, 2019	BUY	$40.12 - $45.47 $373,116 - $422,871	9,300 New	9,300 $36,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.